Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
Atopic dermatitis (AD) is a very common inflammatory, genetic skin disorder that occurs more
frequently in children. Its exact etiology is not known but it is characterized by pruritic
skin reactions with elevation in the levels of inflammatory markers. Corticosteroids are the
first line and the mainstay therapy in management of atopic dermatitis but have many local
and systemic adverse effects. The study aims to evaluate the efficacy and safety of topical
tacrolimus ointment in comparison to topical hydrocortisone cream in management of children
diagnosed with atopic dermatitis.
Phase:
Phase 4
Details
Lead Sponsor:
Ain Shams University
Collaborator:
National Hepatology & Tropical Medicine Research Institute